Logo image of ALREA.PA

REALITES (ALREA.PA) Stock Fundamental Analysis

EPA:ALREA - Euronext Paris - Matif - FR0011858190 - Common Stock - Currency: EUR

1.26  +0.03 (+2.86%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALREA. ALREA was compared to 75 industry peers in the Real Estate Management & Development industry. ALREA may be in some trouble as it scores bad on both profitability and health. ALREA is valied quite expensively at the moment, while it does show a decent growth rate. ALREA also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALREA has reported negative net income.
In the past year ALREA has reported a negative cash flow from operations.
ALREA had positive earnings in each of the past 5 years.
In the past 5 years ALREA always reported negative operating cash flow.
ALREA.PA Yearly Net Income VS EBIT VS OCF VS FCFALREA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

The Return On Assets of ALREA (-8.46%) is worse than 68.00% of its industry peers.
Looking at the Return On Equity, with a value of -263.66%, ALREA is doing worse than 78.67% of the companies in the same industry.
Industry RankSector Rank
ROA -8.46%
ROE -263.66%
ROIC N/A
ROA(3y)0.85%
ROA(5y)1.16%
ROE(3y)6.67%
ROE(5y)8.11%
ROIC(3y)N/A
ROIC(5y)N/A
ALREA.PA Yearly ROA, ROE, ROICALREA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

ALREA's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of ALREA has declined.
The Gross Margin of ALREA (6.23%) is worse than 64.00% of its industry peers.
In the last couple of years the Gross Margin of ALREA has declined.
ALREA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.23%
OM growth 3Y-9.64%
OM growth 5Y-8.44%
PM growth 3Y-39.02%
PM growth 5Y-26.59%
GM growth 3Y-21.24%
GM growth 5Y-8.32%
ALREA.PA Yearly Profit, Operating, Gross MarginsALREA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

2

2. Health

2.1 Basic Checks

ALREA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALREA has less shares outstanding
Compared to 5 years ago, ALREA has more shares outstanding
The debt/assets ratio for ALREA has been reduced compared to a year ago.
ALREA.PA Yearly Shares OutstandingALREA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALREA.PA Yearly Total Debt VS Total AssetsALREA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.13, we must say that ALREA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALREA (0.13) is worse than 62.67% of its industry peers.
A Debt/Equity ratio of 5.29 is on the high side and indicates that ALREA has dependencies on debt financing.
ALREA has a worse Debt to Equity ratio (5.29) than 78.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.29
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC4.13%
ALREA.PA Yearly LT Debt VS Equity VS FCFALREA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

ALREA has a Current Ratio of 1.12. This is a normal value and indicates that ALREA is financially healthy and should not expect problems in meeting its short term obligations.
ALREA's Current ratio of 1.12 is in line compared to the rest of the industry. ALREA outperforms 48.00% of its industry peers.
ALREA has a Quick Ratio of 1.12. This is a bad value and indicates that ALREA is not financially healthy enough and could expect problems in meeting its short term obligations.
ALREA's Quick ratio of 0.60 is in line compared to the rest of the industry. ALREA outperforms 46.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.6
ALREA.PA Yearly Current Assets VS Current LiabilitesALREA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for ALREA have decreased strongly by -749.71% in the last year.
ALREA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.27% yearly.
Looking at the last year, ALREA shows a very negative growth in Revenue. The Revenue has decreased by -14.96% in the last year.
Measured over the past years, ALREA shows a very strong growth in Revenue. The Revenue has been growing by 24.65% on average per year.
EPS 1Y (TTM)-749.71%
EPS 3Y-27.37%
EPS 5Y-18.27%
EPS Q2Q%-2429.92%
Revenue 1Y (TTM)-14.96%
Revenue growth 3Y25.21%
Revenue growth 5Y24.65%
Sales Q2Q%-35.09%

3.2 Future

ALREA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.57% yearly.
The Revenue is expected to grow by 4.30% on average over the next years.
EPS Next Y-92.63%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
EPS Next 5YN/A
Revenue Next Year-19.74%
Revenue Next 2Y-0.24%
Revenue Next 3Y4.3%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALREA.PA Yearly Revenue VS EstimatesALREA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ALREA.PA Yearly EPS VS EstimatesALREA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

ALREA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 1.22, the valuation of ALREA can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALREA indicates a rather cheap valuation: ALREA is cheaper than 98.67% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ALREA to the average of the S&P500 Index (22.10), we can say ALREA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.22
ALREA.PA Price Earnings VS Forward Price EarningsALREA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALREA.PA Per share dataALREA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as ALREA's earnings are expected to decrease with -5.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%

7

5. Dividend

5.1 Amount

ALREA has a Yearly Dividend Yield of 8.89%, which is a nice return.
The stock price of ALREA dropped by -26.96% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
ALREA's Dividend Yield is rather good when compared to the industry average which is at 7.15. ALREA pays more dividend than 90.67% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, ALREA pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.89%

5.2 History

The dividend of ALREA is nicely growing with an annual growth rate of 23.88%!
Dividend Growth(5Y)23.88%
Div Incr Years0
Div Non Decr Years0
ALREA.PA Yearly Dividends per shareALREA.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
ALREA.PA Yearly Income VS Free CF VS DividendALREA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

REALITES

EPA:ALREA (3/7/2025, 7:00:00 PM)

1.26

+0.03 (+2.86%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-25 2024-07-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners57.55%
Ins Owner ChangeN/A
Market Cap6.04M
Analysts86.67
Price Target17.85 (1316.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 8.89%
Yearly Dividend1.45
Dividend Growth(5Y)23.88%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.22
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.19
P/tB 0.24
EV/EBITDA N/A
EPS(TTM)-17.82
EYN/A
EPS(NY)1.03
Fwd EY81.75%
FCF(TTM)-11.51
FCFYN/A
OCF(TTM)-12.8
OCFYN/A
SpS70.22
BVpS6.75
TBVpS5.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.46%
ROE -263.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.23%
FCFM N/A
ROA(3y)0.85%
ROA(5y)1.16%
ROE(3y)6.67%
ROE(5y)8.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.63%
ROCE(5y)5.41%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.64%
OM growth 5Y-8.44%
PM growth 3Y-39.02%
PM growth 5Y-26.59%
GM growth 3Y-21.24%
GM growth 5Y-8.32%
F-Score2
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 5.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.27%
Cap/Sales 1.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.6
Altman-Z 0.13
F-Score2
WACC4.13%
ROIC/WACCN/A
Cap/Depr(3y)86.13%
Cap/Depr(5y)113.76%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-749.71%
EPS 3Y-27.37%
EPS 5Y-18.27%
EPS Q2Q%-2429.92%
EPS Next Y-92.63%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.96%
Revenue growth 3Y25.21%
Revenue growth 5Y24.65%
Sales Q2Q%-35.09%
Revenue Next Year-19.74%
Revenue Next 2Y-0.24%
Revenue Next 3Y4.3%
Revenue Next 5YN/A
EBIT growth 1Y-308.42%
EBIT growth 3Y13.14%
EBIT growth 5Y14.13%
EBIT Next Year149.51%
EBIT Next 3Y68.3%
EBIT Next 5YN/A
FCF growth 1Y0.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.11%
OCF growth 3YN/A
OCF growth 5YN/A